Efectividad Del Plasma Rico en Plaquetas (PRP) Para la disminución Objetiva Del Dolor y la recuperación Funcional Del Miembro Inferior en Osteoartritis de Rodilla. Evaluación de Alternativas metodológicas

Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

Osteoarthritis (OA) is a disease that affects the joints of the body, causing pain, stiffness, and reduced mobility. To treat knee OA, a therapy called platelet-rich plasma (PRP) is used, which involves making a concentrated substance from the patient's own blood and injecting it into the joint. It has been shown that this therapy is effective in reducing pain; however, more research is needed to optimize the preparation and identify which patients are more receptive to the treatment. The primary objective of this study is to evaluate two modalities of PRP application and determine whether these treatments result in better pain reduction and improved functionality. The secondary objective is to explore the association between changes in LEFS questionnaire scores and/or maximal quadriceps isometric strength and possible clinical improvement.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 35
Healthy Volunteers: f
View:

• Radiological diagnosis of knee OA

• Age over 35 years old

• WOMAC value of 24 or higher at the time of recruitment

Locations
Other Locations
Argentina
Institute for Research and Development in Bioengineering and Bioinformatics (IBB-CONICET-UNER)
RECRUITING
Oro Verde
Contact Information
Primary
Pablo Schierloh, PhD
pablo.schierloh@uner.edu.ar
+5491131325656
Backup
Facundo N Urteaga, PhD Student
facundo.urteaga@uner.edu.ar
+54113425110760
Time Frame
Start Date: 2024-05-01
Estimated Completion Date: 2025-09
Participants
Target number of participants: 110
Treatments
Experimental: PRP-1
Platelet-rich plasma, short treatment (three sessions every two weeks)
Active_comparator: PRP-2
Platelet-rich plasma, long treatment (three sessions every four weeks)
Related Therapeutic Areas
Sponsors
Leads: Universidad Nacional de Entre Rios
Collaborators: National Council of Scientific and Technical Research, Argentina

This content was sourced from clinicaltrials.gov

Similar Clinical Trials